Evaluating the Cosmeceutical Peptide Library

Doctor Drelos discusses the role of peptides in cosmeceuticals, particularly in relation to aging skin. He outlines the distinctions between peptides and growth factors, emphasizing that while peptides are smaller and serve various functions in skin homeostasis, they are not as powerful as injectables or procedures. The conversation includes observations about aging differences between men and women, with women aging roughly a decade faster due to menopause impacts. Drelos explains cellular senescence and chronic inflammation as drivers of aging, positing that peptides could potentially influence these processes to restore skin structure. He classifies peptides into categories such as signal peptides, enzyme inhibitors, and neurotransmitter inhibitors, each with distinct effects. While he acknowledges the promise of peptides in enhancing collagen and improving skin elasticity, he also calls for tempered expectations regarding their efficacy. Drelos highlights one notable peptide, OS01, which specifically addresses cellular senescence and promotes DNA repair, indicating a potential future trend in effective peptide development. Ultimately, he suggests that while peptides may not yield dramatic results, they can play a meaningful role in a skincare routine alongside other treatments.